Acasă › Cancer de prostată › Oklahoma › Oklahoma City
Studii clinice pentru Cancer de prostată în Oklahoma City, OK
21 studii pentru Cancer de prostată caută participanți în și în jurul orașului Oklahoma City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
The Vanguard Study: Testing a New Way to Screen for Cancer
În curs de recrutareVoluntari sănătoși bineveniți
- University of Oklahoma Health Sciences Center, Oklahoma City
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
În curs de recrutareFaza 1/2
- University of Oklahoma, Oklahoma City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
În curs de recrutareFaza 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Mercy Hospital Oklahoma City, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
În curs de recrutareFaza 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
În curs de recrutareFaza 3
- Oklahoma Proton Center, Oklahoma City
Protoacoustic Imaging For 3D Mapping
În curs de recrutareStudiu observațional
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
În curs de recrutareFaza 3
- Hightower Clinical, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
În curs de recrutareStudiu observațional
- OU Health Stephenson Cancer Center, Oklahoma City
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
În curs de recrutare
- University of Oklahoma HSC, Oklahoma City
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
În curs de recrutareFaza 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
În curs de recrutareStudiu observațional
- OU Health Stephenson Cancer Center, Oklahoma City
Connect2Care: Prostate Cancer Education and Screenings for African American Men
În curs de recrutare
- TSET Health Promotion Research Center, Oklahoma City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
În curs de recrutareFaza 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #13, Oklahoma City
Studii pentru Cancer de prostată în alte orașe
- New York City, NY103 studii
- Houston, TX76 studii
- Los Angeles, CA61 studii
- Boston, MA59 studii
- St. Louis, MO46 studii
- Chicago, IL45 studii
- San Francisco, CA45 studii
- Philadelphia, PA44 studii
- Baltimore, MD43 studii
- Nashville, TN43 studii
- Seattle, WA42 studii
- Washington, DC38 studii
Alte studii în Oklahoma City
- Cancer pulmonar cu celule non-pătrate28 studii
- Cancer ovarian28 studii
- Cancer endometrial25 studii
- Cancer colorectal22 studii
- Cancer pulmonar19 studii
- Cancer de sân17 studii
- Cancer metastatic16 studii
- Cancer (toate tipurile)14 studii
- Leucemie mieloasă acută14 studii
- Carcinom cu celule scuamoase de cap și gât13 studii
- Cancer de vezică urinară11 studii
- Cancer pancreatic11 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.